MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Levi Garraway
Levi GarrawayROCHE HOLDINGS AG

Levi Garraway

Head of Product Development and Chief Medical Officer at ROCHE HOLDINGS AG

Manager

Deal Bio

Total Deals1
Valued Deals1
Total Value£ 1.19 B
Avg. Deal Size£ 1.19 B

Market Context

Sort

26 Nov 2024|United States|Pharmaceuticals
Poseida Therapeutics
Roche Holdings

Target: POSEIDA THERAPEUTICS

Bidder: ROCHE HOLDINGS AG

10 Service Providers

4 Target | 3 Bidder | 3 Vendor

107 Dealmakers

84 Target | 20 Bidder | 4 Vendor

£ 1.19 B

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite